US Stock MarketDetailed Quotes

NBY NovaBay Pharmaceuticals

Watchlist
  • 0.5299
  • +0.0258+5.12%
Close Dec 20 16:00 ET
  • 0.5100
  • -0.0199-3.76%
Post 19:59 ET
2.59MMarket Cap-0.01P/E (TTM)

About NovaBay Pharmaceuticals Company

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Company Profile

SymbolNBY
Company NameNovaBay Pharmaceuticals
Listing DateOct 26, 2007
Issue Price4.00
Founded2000
CEOMr. Justin M. Hall
MarketAMEX
Employees26
Fiscal Year Ends12-31
Address2000 Powell Street,Suite 1150
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608-1866
Phone1-510-899-8800
Websitehttp://www.novabay.com

Company Executives

  • Name
  • Position
  • Salary
  • Justin M. Hall
  • Chief Executive Officer, Director, Chief Compliance Officer and General Counsel
  • 364.15K
  • Tommy Law
  • Corporate Controller, Interim Chief Financial Officer and Treasurer
  • 177.70K
  • Paul E. Freiman, PhD
  • Chairman of the Board
  • 78.08K
  • Yongxiang Zheng
  • Director
  • 40.58K
  • Mijia Wu, M.B.A.
  • Director
  • 40.58K
  • Julie Garlikov
  • Independent Director
  • 40.58K
  • Dr. Yanyou Zheng, PhD
  • Independent Director
  • 74.08K
  • Swan Sit
  • Independent Director
  • 59.08K
Heat List
US
Overall
Symbol
Price
% Chg

No Data